<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref150">
 <mixed-citation publication-type="journal" id="cit150">
  <name>
   <surname>Sekimukai</surname>
   <given-names>H.</given-names>
  </name>; 
  <name>
   <surname>Iwata-Yoshikawa</surname>
   <given-names>N.</given-names>
  </name>; 
  <name>
   <surname>Fukushi</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Tani</surname>
   <given-names>H.</given-names>
  </name>; 
  <name>
   <surname>Kataoka</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Suzuki</surname>
   <given-names>T.</given-names>
  </name>; 
  <name>
   <surname>Hasegawa</surname>
   <given-names>H.</given-names>
  </name>; 
  <name>
   <surname>Niikura</surname>
   <given-names>K.</given-names>
  </name>; 
  <name>
   <surname>Arai</surname>
   <given-names>K.</given-names>
  </name>; 
  <name>
   <surname>Nagata</surname>
   <given-names>N.</given-names>
  </name>
  <article-title>Gold Nanoparticle-Adjuvanted S Protein Induces a Strong Antigen-specific IgG Response against Severe Acute Respiratory Syndrome-Related Coronavirus Infection, but Fails to Induce Protective Antibodies and Limit Eosinophilic Infiltration in Lungs</article-title>. 
  <source>Microbiol. Immunol.</source>
  <year>2020</year>, 
  <volume>64</volume>, 
  <fpage>33</fpage>â€“
  <lpage>51</lpage>. 
  <pub-id pub-id-type="doi">10.1111/1348-0421.12754</pub-id>.
  <pub-id pub-id-type="pmid">31692019</pub-id>
 </mixed-citation>
</ref>
